ORIGINAL ARTICLE
ELECTROPHYSIOLOGICAL AND ELECTROACOUSTIC ASSESSMENT OF HEARING IN INDIVIDUALS WITH NEUROFIBROMATOSIS TYPE 1
| 1 | Speech Therapy Department and Audiology, Federal University of São Paulo, Brazil |
| 2 | Department of Neurology and Neurosurgery, Support Group for Adolescents and Children with Cancer from Federal University of São Paulo, Brazil |
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
CORRESPONDING AUTHOR
Raquel Caroline Ferreira Lopes Fontanelli
Speech Therapy Department and Audiology, Federal University of São Paulo, Rua Botucatu, 802, 04023-062, São Paulo, Brazil
Speech Therapy Department and Audiology, Federal University of São Paulo, Rua Botucatu, 802, 04023-062, São Paulo, Brazil
Publication date: 2021-03-31
J Hear Sci 2021;11(1):46–53
KEYWORDS
brain stemotoacoustic emissionshearing disordersauditory aathwaysneurofibromatosis type 1hearing tests
TOPICS
ABSTRACT
Background:
Type 1 neurofibromatosis occurs in 1 in every 3,000 individuals, representing 90% of cases of neurofibromatosis. Hearing impairments are not commonly described as an alteration resulting from the pathology; however, sensorineural hearing losses with retrocochlear characteristics may occur as a result of the presence of acoustic neurinomas.
Objectives:
To assess the electrophysiological and electroacoustic hearing characteristics of individuals with neurofibromatosis type 1.
Material and methods:
We assessed 15 patients, 10 females and 5 males, aged between 9 and 31 years, using the following procedures: pure tone audiometry, transient evoked otoacoustic emissions, contralateral suppression of otoacoustic emissions, and brainstem auditory evoked potentials.
Results:
All individuals presented auditory thresholds within normal limits. The mean amplitude of the general responses of otoacoustic emissions in the right and left ears were 11.8 and 12.8 dB, respectively; the suppression effect of otoacoustic emissions was present in 73.3% for the right ear and 66.7% for the left. For brainstem auditory evoked potentials, we obtained mean wave latencies for the right and left ears respectively of wave I: 1.83 and 1.80 ms, III: 4.08 and 4.15 ms, and V: 5.96 and 6.09 ms.
Conclusions:
Individuals with neurofibromatosis type 1 present auditory thresholds within normal limits, present transient otoacoustic emissions, the nonsystematic presence of the suppression effect of otoacoustic emissions and prolonged latencies in brainstem auditory evoked potentials.
Type 1 neurofibromatosis occurs in 1 in every 3,000 individuals, representing 90% of cases of neurofibromatosis. Hearing impairments are not commonly described as an alteration resulting from the pathology; however, sensorineural hearing losses with retrocochlear characteristics may occur as a result of the presence of acoustic neurinomas.
Objectives:
To assess the electrophysiological and electroacoustic hearing characteristics of individuals with neurofibromatosis type 1.
Material and methods:
We assessed 15 patients, 10 females and 5 males, aged between 9 and 31 years, using the following procedures: pure tone audiometry, transient evoked otoacoustic emissions, contralateral suppression of otoacoustic emissions, and brainstem auditory evoked potentials.
Results:
All individuals presented auditory thresholds within normal limits. The mean amplitude of the general responses of otoacoustic emissions in the right and left ears were 11.8 and 12.8 dB, respectively; the suppression effect of otoacoustic emissions was present in 73.3% for the right ear and 66.7% for the left. For brainstem auditory evoked potentials, we obtained mean wave latencies for the right and left ears respectively of wave I: 1.83 and 1.80 ms, III: 4.08 and 4.15 ms, and V: 5.96 and 6.09 ms.
Conclusions:
Individuals with neurofibromatosis type 1 present auditory thresholds within normal limits, present transient otoacoustic emissions, the nonsystematic presence of the suppression effect of otoacoustic emissions and prolonged latencies in brainstem auditory evoked potentials.
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.